Lepidoglyphus Destructor

Lepidoglyphus destructor is a type of mite that can cause allergies in some people. Researchers are conducting clinical trials to better understand how to diagnose and potentially treat allergies related to this mite. These studies involve using extracts of Lepidoglyphus destructor in skin prick tests to measure allergic reactions and determine the most effective concentrations for diagnosis and treatment.

Table of Contents

What is Lepidoglyphus Destructor?

Lepidoglyphus destructor is a type of mite that can cause allergies in some people. It’s often found in stored grains and house dust. When people who are allergic to this mite come into contact with it, they may experience symptoms like sneezing, runny nose, or breathing difficulties[1].

Medical Use

Extracts from Lepidoglyphus destructor are used in medicine to diagnose allergies. Doctors use these extracts to perform tests that help determine if a person is allergic to this specific mite. This information is crucial for developing appropriate treatment plans for patients with allergies[1][2].

The extract is used in a procedure called a skin prick test. This test helps doctors identify allergies to various substances, including Lepidoglyphus destructor. It’s particularly useful for diagnosing conditions such as:

  • Allergic rhinitis: This is inflammation of the inside of the nose caused by an allergen, like dust or pollen.
  • Rhinoconjunctivitis: This condition affects both the nose and eyes, causing symptoms in both areas.
  • Allergic asthma: This is a type of asthma triggered by inhaled allergens.

How It’s Tested

The Lepidoglyphus destructor extract is used in a solution for skin prick tests. During these tests, a small amount of the solution is placed on the skin, usually on the forearm or back. The skin is then gently pricked to allow a tiny amount of the solution to enter the skin[1].

If a person is allergic to Lepidoglyphus destructor, a small, raised bump (called a wheal) will appear on the skin where the solution was applied. The size of this bump is compared to the reaction caused by a substance called histamine, which is used as a control in the test[1][2].

Who Can Be Tested?

Not everyone is eligible for this allergy test. Generally, candidates for testing include:

  • People aged 18 to 65 years old
  • Those with a history of allergies, especially to inhaled substances
  • Individuals who have previously shown positive results in allergy tests or have specific antibodies (IgE) to Lepidoglyphus destructor

However, certain factors may prevent someone from being tested, such as[1][2]:

  • Pregnancy or breastfeeding
  • Certain skin conditions that could interfere with the test results
  • Use of certain medications that could affect the results
  • History of severe reactions to skin tests

Testing Procedure

The testing procedure involves several steps:

  1. A small drop of the Lepidoglyphus destructor extract is placed on the skin.
  2. The skin is gently pricked to allow the solution to enter.
  3. The area is observed for about 15-20 minutes.
  4. If an allergy is present, a small, raised bump (wheal) will appear.
  5. The size of this bump is measured and compared to the reaction caused by histamine.

The test aims to find the concentration of Lepidoglyphus destructor extract that causes a reaction similar in size to that produced by a standard concentration of histamine. This helps in standardizing the potency of the allergen extract[1][2].

Safety and Precautions

While skin prick tests are generally safe, there are some precautions to be aware of:

  • The test should be performed by trained healthcare professionals.
  • Patients should inform their doctor about all medications they’re taking, as some may interfere with the test results.
  • In rare cases, more severe allergic reactions can occur. Therefore, the test is performed in a medical setting where any reactions can be promptly treated.
  • Patients with a history of severe allergic reactions may not be suitable for this test.

It’s important to follow all instructions provided by your healthcare provider before, during, and after the test to ensure safety and accuracy of results[1][2].

Aspect Details
Main Objective To determine the concentration of Lepidoglyphus destructor extract that causes a skin reaction equivalent to a 10 mg/mL histamine solution
Study Population Adults aged 18-65 with a history of allergy to Lepidoglyphus destructor
Key Inclusion Criteria Positive allergy history, positive skin prick test or specific IgE to Lepidoglyphus destructor
Key Exclusion Criteria Recent immunotherapy, severe allergic reactions, pregnancy, certain medications
Primary Endpoint Wheal area (mm²) produced by Lepidoglyphus destructor extract compared to histamine
Secondary Objectives Determine in vitro biological potency, evaluate tolerability and safety

Ongoing Clinical Trials on Lepidoglyphus Destructor

  • Study of Lepidoglyphus destructor allergen extract using skin prick tests in patients with allergies

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

    Not recruiting

    2 1 1
    Investigated diseases:
    Spain

Glossary

  • Lepidoglyphus destructor: A type of mite commonly found in house dust that can cause allergic reactions in some people.
  • Skin prick test: A method used to diagnose allergies by applying a small amount of an allergen to the skin and observing the reaction.
  • Wheal: A raised, itchy area on the skin that appears during an allergic reaction, often measured in allergy tests.
  • Histamine: A substance released by the body during allergic reactions, used as a comparison in allergy tests.
  • IgE (Immunoglobulin E): An antibody produced by the immune system in response to allergens, often measured to diagnose allergies.
  • HEP (Histamine Equivalent Prick): A unit used to measure the potency of allergen extracts in relation to a standard histamine solution.
  • Rhinitis: Inflammation of the nasal passages, often causing a runny or stuffy nose, sneezing, and itching.
  • Rhinoconjunctivitis: A condition involving inflammation of both the nasal passages and the eyes, common in allergic reactions.
  • Immunotherapy: A treatment approach that aims to reduce allergic sensitivity by exposing the patient to gradually increasing doses of an allergen.

References

  1. http://clinicaltrials.eu/trial/study-on-allergy-to-lepidoglyphus-destructor-testing-with-lepidoglyphus-destructor-extract-histamine-hydrochloride-and-sodium-chloride-in-affected-patients/
  2. http://clinicaltrials.eu/trial/study-on-allergenic-extracts-of-mites-and-histamine-dihydrochloride-for-allergy-patients/